tiprankstipranks

Harshad Angel - New Portfolio

HARSHAD SOLANKI

Harshad Angel
Individual Investor
Ranked #57,739 out of 769,002 TipRanks' Investors
Success Rate
51%
43 out of 84
profitable transactions
Average Return
63.01%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 3.42%
6-Month Return▼ 3.92%
12-Month Return▲ 37.96%
YTD Return▲ 23.96%
Total Return▲ 37.83%

Best Trade

Opened at
Closed at-
Gain▲ 1620.83%

Bio

Managing my funds for maximum returns

Performance

25.72%0-25.72%
▼ 12.40%
▼ 4.03%
▼ 9.34%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 23.99%
May 2024
▼ 2.25%
▲ 3.53%
▼ 15.66%
Jun 2024
▲ 25.72%
▲ 1.21%
▲ 8.05%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 9.65%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 4.84%
Sep 2024
▲ 5.70%
▼ 0.89%
▼ 0.17%
Oct 2024
▲ 23.63%
▲ 3.84%
▲ 10.42%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%▼ 9.34%
▲ 11.46%▲ 5.06%▲ 23.99%
▼ 2.25%▲ 3.53%▼ 15.66%
▲ 25.72%▲ 1.21%▲ 8.05%
▼ 4.22%▲ 2.34%▼ 9.65%
▲ 7.82%▲ 2.10%▲ 4.84%
▲ 5.70%▼ 0.89%▼ 0.17%
▲ 23.63%▲ 3.84%▲ 10.42%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Plug Power
3.16%
▼ 29.55%
14
Buy
Oct 21, 2024
TScan Therapeutics
2.19%
▼ 22.96%
6
Sell
Oct 21, 2024
Taysha Gene Therapies
8.5%
▼ 8.75%
9
Buy
Oct 21, 2024
Fuelcell Energy
0.01%
▲ 895.08%
9
Sell
Oct 21, 2024
Nvidia
81.67%
▲ 48.71%
13
Sell
Oct 21, 2024
BioCryst
0.83%
▲ 40.97%
8
Buy
Oct 21, 2024
Vuzix
0%
▼ 15.79%
4
Sell
Oct 21, 2024
Costco
0.27%
▲ 7.62%
3
Buy
Oct 21, 2024
Akebia Therapeutics
1.01%
▲ 30.66%
1
Open
Oct 21, 2024
Oncolytics Biotech
0.55%
▼ 20.79%
1
Open
Oct 21, 2024
Sonnet BioTherapeutics Holdings
0.2%
▼ 71.28%
5
Buy
Sep 13, 2024
Agenus
1.62%
▼ 66.23%
6
Sell
Sep 06, 2024
Atara Biotherapeutics
0%
▼ 24.59%
10
Sell
Sep 06, 2024
Alphabet Class A
0%
▲ 7.50%
9
Sell
Sep 06, 2024
Advanced Micro Devices
0%
▼ 11.74%
7
Sell
Sep 06, 2024
Amazon
0%
▲ 15.65%
6
Sell
Jun 28, 2024
Tesla
0%
▲ 99.43%
4
Sell
Jun 21, 2024
Meta Platforms
0%
▲ 28.66%
5
Buy
Jun 13, 2024
Bitcoin
0%
▲ 59.41%
1
Open
May 01, 2024
Ethereum
0%
▲ 2.82%
1
Open
May 01, 2024